Nephrologie et Therapeutique

Aims & Scope

Official journal of the French-speaking society of nephrology, dialysis and transplantation (SFNDT) and of the French society of paediatric nephrology, Néphrologie & Thérapeutique publishes articles updating knowledge in nephrology: recommendations of good clinical practice, original research, or professional information from the two founding societies.

The variety of topics covered reflects the richness of nephrology, whether fundamental aspects of physiology, immunology, pathology, or genetics, or subjects of clinical nephrology, especially those related to nephrological therapeutics, transplantation, haemodialysis and peritoneal dialysis.

The journal publishes articles in French or in English and will consider manuscripts submitted in either language.

View Aims & Scope

---

Metrics & Ranking

SJR (SCImago Journal Rank)

Year	Value
2024	0.252

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	30

Impact Factor

Year	Value
2024	0.70

Journal Rank

Year	Value
2024	18519

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Acute kidney injury and chronic kidney disease: From the laboratory to the clinic

  Citation: 119

  Authors: David A., Joseph V.

• Orthostatic hypotension: A review

  Citation: 86

  Authors: Adrien, Ruben, Martin, Emmanuelle

• Anxiété et dépression en hémodialyse : validation de l’Hospital Anxiety and Depression Scale (HADS)

  Citation: 67

  Authors: Aurélie, Maider, Philippe, Eric, Christian, Nicole

• Uremic toxicity and sclerostin in chronic kidney disease patients

  Citation: 65

  Authors: Lucie, Sophie, Rodriguo B., Loïc, Saïd, Horst-Dieter, Raymond, Gabriel, Ziad A.

• Effets vasculaires et rénaux des médicaments anti-angiogéniques : recommandations françaises pour la pratique (SN, SFHTA, APNET, FFCD)

  Citation: 59

  Authors: Jean-Michel, Michel, Guillaume, Olivier, Gilbert, Gaetan, Thierry, Bernard, Jean-Jacques, Dominique, Stéphane, Philippe, Dil

• New insights on inflammation in chronic kidney disease–genetic and non-genetic factors

  Citation: 52

  Authors: Peter

• Prognosis and treatment of diabetic nephropathy: Recent advances and perspectives

  Citation: 46

  Authors: Peter, Frederik, Marie

• Coût de la prise en charge de l’IRCT en France en 2007 et impact potentiel d’une augmentation du recours à la dialyse péritonéale et à la greffe

  Citation: 45

  Authors: Pierre-Olivier, Philippe, Alain, Philippe, Hubert

• The contribution of adult stem cells to renal repair

  Citation: 44

  Authors: Benjamin D., Joseph V.

• Clinical spectrum of primary hyperoxaluria type 1: Experience of a tertiary center

  Citation: 40

  Authors: Neveen A., Marwa M., Safaa M., Hanan, Rasha, Khaled, Hafez M., Ahmed M., Omar A., Magd A., Khaled M., Alaa

---